It is reported that many other mechanisms like induced ROS generation, targeted p53 pathway, and ER stress were involved in the anti-melanoma action of shikonin (Wu et al., 2004; Liu et al., 2019b), we could not exclude the possibilities that shikonin could modulate other mechanisms that regulate cell response. Here, TP53 is linked to melanoma.